Tikun Olam (cannabis)

History and Establishment:

• In the late 1990s, Israel’s Ministry of Health initiated medical cannabis use.
• Tikun Olam was founded in 2005 specifically to grow cannabis for medical purposes.
• By 2010, the Ministry of Health had regulated medical marijuana in Israel.
• Tikun Olam’s strain Erez, with 23% active ingredients, gained popularity.
• By 2013, Tikun Olam was serving around 3,000 patients monthly.

Production and Innovation:

• Tikun Olam focuses on growing medical cannabis strains with high percentages of active ingredients.
• The company developed a unique strain known for its anti-inflammatory properties.
• Professor Mechoulam at Hebrew University oversaw substance testing and quality checks.
• As of 2014, Tikun Olam had cultivated 12 different strains.
• The company also produces various cannabis products, including edible capsules.

International Expansion:

• Tikun Olam California established a 5.7-hectare indoor cultivation facility in Adelanto, near Los Angeles, in 2019.
• This marked Tikun Olam’s entry into the US market, aiming to broaden its global presence.
• International expansion allowed Tikun Olam to reach a wider customer base.

Media Recognition:

• Various media outlets, such as Medical Breakthrough, The Times of Israel, וואלה! חדשות, ברק רוזן חטף לאהוד ברק את פעילות תיקון עולם בישראל, and Daily Press, have recognized Tikun Olam’s growth and achievements.

Impact and Reach:

• Tikun Olam’s focus on medical cannabis has had a significant impact on the industry.
• The company’s expansion efforts, including international ventures, have helped it reach a wider customer base and establish a global presence.

Tikun Olam (cannabis) Data Sources